Skip to main content

Overview of Drug-Resistant Pulmonary Tuberculosis

  • Chapter
  • First Online:
Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis

Abstract

Drug resistance in Mycobacterium pulmonary tuberculosis is defined as in vitro tests that confirm that Mycobacterium pulmonary tuberculosis has developed resistance to one or more antituberculosis drugs. Drug resistance in Mycobacterium pulmonary tuberculosis can be classified into four types based on laboratory bacteriology and the causes of drug resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tang SHJ, Gao W. Clinical tuberculosis [M]. First2 edition. Beijing: People’s Health Publishing House; 2019.

    Google Scholar 

  2. World Health Organization. Definitions and reporting framework for tuberculosis-2013 revision [R]. Geneva: World Health Organization; 2013. https://apps.who.int/iris/handle/10665/79199.

    Google Scholar 

  3. Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27–29 Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis, 27–29 October 2020 [EB/OL]. Geneva: World Health Organization; 2021. https://apps.who.int/iris/handle/10665/338776.

  4. World Health Organization. WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis [R]. Geneva: World Health Organization; 2018. https://apps.who.int/iris/handle/10665/260494.

    Google Scholar 

  5. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008 [R]. Geneva: World Health Organization; 2008. https://apps.who.int/iris/handle/10665/43965.

    Google Scholar 

  6. Piubello A, Aït-Khaled N, Caminero JA, et al. Field guide for the management of drug-resistant tuberculosis 2018[R]. Paris: International Union Against Tuberculosis and Lung Disease, 2018.

    Google Scholar 

  7. He GX, Wang LX. Evolution of tuberculosis control strategies [J]. Prevent Med Forum. 2008;14(6):481–4.

    Google Scholar 

  8. Shen X, Mei J, Gao Q. DOTS-Plus: a powerful weapon for controlling multidrug-resistant tuberculosis [J]. Shanghai J Prevent Med. 2006;18(5):225–6.

    Google Scholar 

  9. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis [R]. Geneva: World Health Organization; 2006. https://apps.who.int/iris/handle/10665/246249.

    Google Scholar 

  10. World Health Organization. The global plan to stop TB 2011–2015: transforming the fight towards elimination of tuberculosis [R]. Geneva: World Health Organization; 2010. https://apps.who.int/iris/handle/10665/44437.

    Google Scholar 

  11. World Health Organization. The end TB strategy [R]. Geneva: World Health Organization; 2014. https://apps.who.int/iris/handle/10665/331326.

    Google Scholar 

  12. World Health Organization. Global tuberculosis report 2021 [EB/OL]. [2021-10-14]. https://www.who.int/publications/digital/global-tuberculosis-report-2021.

  13. World Health Organization. Global tuberculosis report 2020 [R]. Geneva: World Health Organization; 2020. https://apps.who.int/iris/handle/10665/336069.

    Google Scholar 

  14. Chunrong L, Hongxia F, Puxuan L, et al. The global tuberculosis report 2021: key data analysis for China and the global world [J/CD]. J Emerg Infect Dis. 2021;6(4):368–72.

    Google Scholar 

  15. World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis [R]. Geneva: World Health Organization; 2014. https://apps.who.int/iris/handle/10665/130918.

    Google Scholar 

  16. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis, 2011 update [R]. Geneva: World Health Organization; 2011. https://apps.who.int/iris/handle/10665/44597.

    Google Scholar 

  17. World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update [R]. Geneva: World Health Organization; 2016. https://apps.who.int/iris/handle/10665/250125.

    Google Scholar 

  18. World Health Organization. Rapid communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB) [R]. Geneva: World Health Organization; 2018. https://apps.who.int/iris/handle/10665/275383.

    Google Scholar 

  19. Yan F. Evaluation of rapid diagnostic methods for drug-resistant tuberculosis and analysis of treatment effects [D]. Nanjing Medical University; 2014.

    Google Scholar 

  20. Wang L, Hu J, Guo Q. Diagnostic value of gene chip technology testing for drug resistance of Mycobacterium tuberculosis [J]. Chin J Pract Diagn Ther. 2018;32(4):393–4.

    Google Scholar 

  21. Lianshuang Z, Di D, Xin C, et al. Diagnostic value of gene microarray in mycobacterial strain identification and tuberculosis drug resistance gene detection [J]. Lab Med Clin. 2014;11(12):1595–8.

    Google Scholar 

  22. World Health Organization. Update on the use of nucleic acid amplification tests to detect TB and drug-resistant TB: rapid communication [R]. Geneva: World Health Organization; 2021. https://apps.who.int/iris/handle/10665/339611.

    Google Scholar 

  23. Accurate molecular diagnostics for remote locations—GeneXpert® Omni [EB/OL]. Cepheid. [2015-08-28]. https://www.rapidmicrobiology.com/news/accurate-molecular-diagnostics-for-remote-locations-genexpert-omni.

  24. Yao WM, Chen CH, Zangya P, et al. Whole-gene sequencing analysis of methicillin-resistant Staphylococcus aureus linezolid resistance-associated variant loci [J]. Chin J Infect Control. 2017;16(1):1–5.

    Google Scholar 

  25. Kim W, Lee KS, Kim HS, et al. CT and microbiologic follow-up in primary multidrug-resistant pulmonary tuberculosis [J]. Acta Radiol. 2016;57(2):197–204.

    Article  PubMed  Google Scholar 

  26. Joshi AR, Mishra S, Sankhe AP, et al. HRCT spectrum of pulmonary multidrug-resistant tuberculosis in HIV negative patients: a study in Indian population [J]. Int J Sci Res. 2017;6(9):596–600.

    Google Scholar 

  27. Lee ES, Park CM, Goo JM, et al. Computed tomography features of extensively drug-resistant pulmonary tuberculosis in non-HIV-infected patients [J]. J Comput Assist Tomogr. 2010;34(4):559–63.

    Article  PubMed  Google Scholar 

  28. Cheon H. Comparison of CT findings of between MDR-TB and XDR-TB: a propensity score matching study [J]. Imaging Med. 2017;9(5):125–9.

    Google Scholar 

  29. Manikkam S, Archary M, Bobat R. Chest X-ray patterns of pulmonary multidrug-resistant tuberculosis in children in a high HIV-prevalence setting [J]. South Afr J Radiol. 2016;20(1):e1–6.

    Google Scholar 

  30. Li D, He W, Chen B, et al. Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: comparisons of CT findings [J]. PLoS One. 2017;12(6):e176354.

    Article  Google Scholar 

  31. Chung MJ, Lee KS, Koh W, et al. Drug-sensitive tuberculosis, multidrug-resistant tuberculosis, and nontuberculous mycobacterial pulmonary disease in non-AIDS adults: comparisons of thin-section CT findings [J]. Eur Radiol. 2006;16(9):1934–41.

    Article  PubMed  Google Scholar 

  32. Kim HC, Goo JM, Lee HJ, et al. Multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in human immunodeficiency virus-negative patients: computed tomography features [J]. J Comput Assist Tomogr. 2004;28(3):366–71.

    Article  PubMed  Google Scholar 

  33. Wang Y-x, Chung MJ, Skrahin A, et al. Literature analysis of radiological signs related to multidrug-resistant tuberculosis [J]. Electron J Emerg Infect Dis. 2018;3(2):244–53.

    Google Scholar 

  34. Luyao M, Qiuting Z, Punxuan L, et al. Pulmonary multi-drug resistant tuberculosis: a radiological review [J]. Emerg Infect Dis. 2021;6(1):58–65.

    Google Scholar 

  35. Liu YH. The role of injectable antituberculosis drugs in the treatment of drug-resistant tuberculosis in China [J]. Chin J Tuberc Respir. 2019;42(6):401–4.

    CAS  Google Scholar 

  36. Would Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment [G]. Geneva: Would Health Organization; 2019. https://apps.who.int/iris/handle/10665/311389.

    Google Scholar 

  37. Moodley R, Godec TR. Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials [J]. Eur Respir Rev. 2016;25(139):29–35.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kurbatova EV, Dalton T, Ershova J, et al. Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries [J]. Emerg Infect Dis. 2015;21(6):977–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Sikuan Y, Pan Z, Chuanli Y, et al. Clinical effect analysis of early surgical treatment of multidrug-resistant pulmonary tuberculosis [J]. J Third Milit Med Univ. 2013;35(7):685–7.

    Google Scholar 

  40. Shenjie T. Review and perspectives on the comprehensive treatment of drug-resistant tuberculosis [J]. J Tuberc Lung Health. 2014;3(3):141–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 People's Medical Publishing House, PR of China

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wang, Yx., Zhang, Jj., Peng, La., Hu, Fx., Mei, Jz., Lu, PX. (2023). Overview of Drug-Resistant Pulmonary Tuberculosis. In: Lu, PX., Lu, Hz., Yi, Yx. (eds) Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis. Springer, Singapore. https://doi.org/10.1007/978-981-99-8339-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-8339-1_1

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-8338-4

  • Online ISBN: 978-981-99-8339-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics